Загрузка...
Synergistic activity of ixabepilone plus other anticancer agents: preclinical and clinical evidence
Ixabepilone demonstrates marked synergistic activity in combination with capecitabine, which served as the rationale for the evaluation of this combination in the clinic. Ixabepilone plus capecitabine is currently approved for patients with locally advanced or metastatic breast cancer (MBC) progress...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2011
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3126033/ https://ncbi.nlm.nih.gov/pubmed/21789152 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834010386402 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|